Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis

World Health Organization.
Geneva; World Health Organization; 2018. (WHO/CDS/TB/2018.5).
em Inglês | WHOLIS | ID: who-260470

Documentos relacionados

  1. Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments.
  2. Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye.
  3. Better and safer treatment for multidrug-resistant tuberculosis.
  4. [Annual progress of immunotherapy for tuberculosis in 2023].
  5. Association between fatty acid metabolism gene mutations and Mycobacterium tuberculosis transmission revealed by whole genome sequencing.
  6. Simple and low-cost antibiotic susceptibility testing for Mycobacterium tuberculosis using screen-printed electrodes.
  7. Challenging the management of drug-resistant tuberculosis.
  8. Challenging the management of drug-resistant tuberculosis - Authors' reply.
  9. Challenging the management of drug-resistant tuberculosis.
  10. Insidious transmission of Mycobacterium tuberculosis in Ordos, China: a molecular epidemiology study.